tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

InhaleRx Issues Over 2.1 Million Unquoted Options Expiring in 2027

Story Highlights
  • InhaleRx has issued 2,154,603 deferred, unquoted options expiring in December 2027.
  • The unquoted options form part of previously announced capital measures, likely supporting targeted incentives or financing rather than public issuance.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
InhaleRx Issues Over 2.1 Million Unquoted Options Expiring in 2027

Claim 70% Off TipRanks This Holiday Season

The latest update is out from InhaleRx Limited ( (AU:IRX) ).

InhaleRx Limited has notified the market of a new issue of unquoted equity securities, consisting of 2,154,603 deferred options (IRXAK) expiring on 22 December 2027. The options, which were previously flagged to the market, are not quoted and are not intended to be quoted on the ASX, indicating a capital management step that may be tied to incentive structures or specific financing arrangements rather than broad public issuance.

More about InhaleRx Limited

Average Trading Volume: 288,524

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$5.39M

Find detailed analytics on IRX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1